Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer

Huang Wen, Pekka Poutiainen, Enkhzaya Batnasan, Leena Latonen, Vesa-Pekka Lehto, Wujun Xu

Open source

DOI
10.3390/pharmaceutics15102507
Published
2023-10-22
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics15102507,
  title = {Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer},
  author = {Huang Wen and Pekka Poutiainen and Enkhzaya Batnasan and Leena Latonen and Vesa-Pekka Lehto and Wujun Xu},
  year = {2023},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics15102507},
  url = {https://doi.org/10.3390/pharmaceutics15102507}
}

RIS

TY  - JOUR
TI  - Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer
AU  - Huang Wen
AU  - Pekka Poutiainen
AU  - Enkhzaya Batnasan
AU  - Leena Latonen
AU  - Vesa-Pekka Lehto
AU  - Wujun Xu
PY  - 2023
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics15102507
UR  - https://doi.org/10.3390/pharmaceutics15102507
ER  - 

APA

Wen, H., Poutiainen, P., Batnasan, E., Latonen, L., Lehto, V., & Xu, W. (2023). Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15102507

Source records